S&P 500

5.431,60

-0,04%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
Skye Bioscience Inc (QB) (SKYE)
Skye Bioscience Inc (QB) (SKYE) Notícias

SKYE

Skye Bioscience (QB) (SKYE)

Skye Bioscience Inc (QB)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:SKYE

1

Data	Hora	Fonte	Título	Código	Companhia
04/03/2024	21:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:SKYE	Skye Bioscience Inc (QB)
04/03/2024	18:23	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:SKYE	Skye Bioscience Inc (QB)
04/03/2024	18:18	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	USOTC:SKYE	Skye Bioscience Inc (QB)
04/03/2024	08:15	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	USOTC:SKYE	Skye Bioscience Inc (QB)
12/02/2024	14:08	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	USOTC:SKYE	Skye Bioscience Inc (QB)
31/01/2024	18:15	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	USOTC:SKYE	Skye Bioscience Inc (QB)
03/10/2023	17:12	Edgar (US Regulatory)	Form PRE 14C - Other preliminary information statements	USOTC:SKYE	Skye Bioscience Inc (QB)
28/08/2023	17:16	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	USOTC:SKYE	Skye Bioscience Inc (QB)
07/08/2023	17:37	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:SKYE	Skye Bioscience Inc (QB)
31/03/2023	17:35	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:SKYE	Skye Bioscience Inc (QB)
27/03/2023	17:10	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:SKYE	Skye Bioscience Inc (QB)
20/03/2023	07:02	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:SKYE	Skye Bioscience Inc (QB)
17/03/2023	15:53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:SKYE	Skye Bioscience Inc (QB)
23/02/2023	19:22	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:SKYE	Skye Bioscience Inc (QB)
16/02/2023	19:38	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:SKYE	Skye Bioscience Inc (QB)
09/01/2023	13:28	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	USOTC:SKYE	Skye Bioscience Inc (QB)
20/12/2022	09:31	InvestorsHub NewsWire	Skye Bioscience Receives FDA Authorization of Investigational New Drug Application for SBI-100 OE	USOTC:SKYE	Skye Bioscience Inc (QB)
16/12/2022	09:57	InvestorsHub NewsWire	Skye Bioscience Doses First Cohort of Participants in Phase 1 Clinical Trial of SBI-100 Ophthalmic Emulsion	USOTC:SKYE	Skye Bioscience Inc (QB)
15/11/2022	17:47	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/a)	USOTC:SKYE	Skye Bioscience Inc (QB)
14/11/2022	17:20	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:SKYE	Skye Bioscience Inc (QB)
01/09/2022	17:01	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:SKYE	Skye Bioscience Inc (QB)
31/01/2022	15:59	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	USOTC:SKYE	Skye Bioscience Inc (QB)
05/01/2022	15:05	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:SKYE	Skye Bioscience Inc (QB)
10/11/2021	10:57	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:SKYE	Skye Bioscience Inc (QB)
28/09/2021	09:31	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	USOTC:SKYE	Skye Bioscience Inc (QB)
10/08/2021	07:04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:SKYE	Skye Bioscience Inc (QB)
17/05/2021	13:24	InvestorsHub NewsWire	Skye Bioscience's THCVHS Demonstrates Superior Therapeutic Benefit Compared to Glaucoma Standard of Care, both as ...cont	USOTC:SKYE	Skye Bioscience Inc (QB)
13/02/2009	19:52	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	USOTC:SKYE	Skye Bioscience Inc (QB)
02/10/2008	12:08	Edgar (US Regulatory)	Skyepharma Plc - Prospectus filed pursuant to Rule 424(b)(3) (424B3)	USOTC:SKYE	Skye Bioscience Inc (QB)
11/02/2008	19:39	Edgar (US Regulatory)	Skyepharma Plc - Amended Statement of Ownership (SC 13G/A)	USOTC:SKYE	Skye Bioscience Inc (QB)